R Shapiro, VP Scantlebury, ML Jordan… - Transplantation …, 1997 - ncbi.nlm.nih.gov
DISCUSSION The diabetogenicity of tacrolimus appears to be related to a reversible effect of tacrolimus on islet cells. FK binding protein (FKBP) is present in islet cells, and decreased …
R Shapiro, V Scantlebury, ML Jordan, C Vivas… - …, 1999 - d-scholarship.pitt.edu
We read with interest the report by Moxey-Mims et aI.," Increased Incidence of Insulin- Dependent Diabetes Mellitus in Pediatric Renal Transplant Patients Receiving Tacrolimus …
T Hasegawa, H Imai, S Miki - Pharmacoeconomics, 2003 - Springer
Background: International phase III studies (CRIB 201 and 352) showed that basiliximab, a high affinity chimeric monoclonal antibody interleukin-2 receptor antagonist, is highly …
S Takahara, T Miki, M Hatori, Y Kokado, J Wang… - Transplant …, 1998 - Springer
Nine renal transplant recipients in stable systemic condition on FK506 capsules were converted to FK506 granules in order to investigate the safety, efficacy, and …